Replies to post #197468 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Nice try. The company SEC statements make it clear that ALL treatments must be given to patients (unless market approval arrives first) as anything other than completing the trial would be considered stoping the trial early and subject to a hefty $3 million fine. You know this.

Stopping the trial early would not trigger the $3M termination clause. I know that.

Stopping the program would, but that is another issue.

Further, treatment dies not stop because a trial is complete. I know that. I assume you do not.